Belimumab: Uses | 合法藥品大搜索

In the US, belimumab is indicated to treat active systemic lupus erythematosus (SLE) and active lupus nephritis in patients aged five years and older who are receiving standard therapy.7 In Europe, belimumab is also used to treat SLE and lupus nephritis but only in adults.8

The efficacy of belimumab has not been evaluated in patients with severe active central nervous system lupus. Use of belimumab is not recommended in this situation.7

Reduce drug development failure rates

Build, train, & validate machine-learning modelswith evidence-based and structured datasets.

Build, train, & validate predictive machine-learning models with structured datasets.